FDA Approves Safety Standards of GLG Stevia ExtractsFDA Approves Safety Standards of GLG Stevia Extracts
The U.S. Food and Drug Administration (FDA) issued a Generally Recognized as Safe (GRAS) letter of no objection covering several of GLG Life Tech Corporation’s high-purity stevia extracts, including its Rebsweet and AnySweetPLUS products.
June 4, 2014
VANCOUVER, British Columbia—The U.S. Food and Drug Administration (FDA) issued a Generally Recognized as Safe (GRAS) letter of no objection covering several of GLG Life Tech Corporation’s high-purity stevia extracts, including its Rebsweet and AnySweetPLUS products.
The GRAS program is an FDA-approved process that enables companies to conduct independent GRAS determinations through consultations with qualified experts to determine that an ingredient satisfies the FDA's safety criteria. Accordingly, GLG engaged GRAS Associates, LLC, who convened an independent panel of expert scientists to spearhead the safety assessment and compile a dossier describing the months-long study and its results. GLG subsequently submitted that dossier to the FDA for review, resulting in the FDA's letter of no objection.
To date, GLG has received five GRAS letters of no objection covering an array of high-purity stevia products, with a sixth GRAS determination pending FDA review (for high-purity rebaudioside M) and two other GRAS projects currently underway (for high-purity rebaudioside C and D). Additionally, GLG recently announced its submission of a GRAS notification to the FDA for its Luo Han Guo (Monk Fruit) extract products. GLG currently has the largest number of stevia products certified under the GRAS process.
You May Also Like
8 ingredients and product format trends driving the shift from sports to active nutritionOct 04, 2023
High prices for lavender oil lead to report on adulteration risksOct 03, 2023
SPINS sales data reveals 7 nutritional ingredient trendsOct 02, 2023
Anti-aging and the science of nicotinamide ribosideOct 02, 2023